Dagyagnao, Carmen A.

HRN: 24-24-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
CEFTRIAXONE 1G (VIAL)
12/11/2023
12/17/2023
IV
2g
OD
Sepsis
Waiting Final Action 
12/11/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/11/2023
12/17/2023
IVT
4.5g
Q6
Complicated UTI
Waiting Final Action 
12/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/12/2023
12/18/2023
IV
500mg
Q8
T/C Ascending Cholangitis
Waiting Final Action 
08/23/2025
CEFTRIAXONE 1G (VIAL)
08/23/2025
08/30/2025
IV
2gm
OD
CUTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: